Healthcare Industry News: Dover
News Release - September 10, 2007
TissueLink Medical Names Richard M. Altieri Vice President and Chief Financial Officer
Dover, N.H.--(HSMN NewsFeed)--TissueLink Medical Inc., a privately held medical device company, announced today the appointment of Richard M. Altieri as Vice President and Chief Financial Officer of the company, effective September 3, 2007.Prior to joining TissueLink, Mr. Altieri had been Senior Vice President of Finance and Chief Financial Officer of Straumann USA, a global leader in the field of implant dentistry and dental tissue regeneration. Previously, Mr. Altieri was Vice President and Chief Financial Officer of Mitek Surgical Products, Inc., where he played a key role in the sale of the company to Johnson & Johnson. As part of the J&J family he was instrumental in Mitek's subsequent growth into a leader in the field of surgical sports medicine. Mr. Altieri is a CPA and earned his BS degree in Accounting from Northeastern University and an MBA from Babson College.
Joe Army, TissueLink's President and CEO commented: "Mr. Altieri is a seasoned executive who brings over 15 years of CFO experience in the medical device market. Rick's background in financial reporting and investor relations in a high growth public company, strategic planning, M&A and direct sale force expansion will enable him to make meaningful contributions to drive growth."
Jay Schmelter, Chairman of TissueLink's Board of Directors commented: "We are pleased to have someone with Mr. Altieri's background and experience join us as CFO. He is a valuable addition to our strong management team."
About TissueLink Medical, Inc.
TissueLink Medical, founded in 1999, is a private company that develops and markets innovative disposable surgical devices that reduce or eliminate bleeding in surgery. Over 100,000 patients worldwide have benefited from the company's products. TissueLink technology is used by surgeons to control bleeding in solid organ resections, orthopaedic reconstruction and spine surgery. The company's proprietary technology can apply to multiple surgical specialties addressing markets that exceed $3.5 billion.
For more information on TissueLink Medical, visit the company website at www.tissuelink.com.
Source: TissueLink Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!